EUVIMEDEUVIMED entdecken
Crossref

Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial

Tatovic D, Marwaha A, Taylor P, Hanna SJ, Carter K, Cheung WY, et al

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.10.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Tatovic D und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

D, T., A, M., P, T., SJ, H., K, C., WY, C., & al, E. (2025). Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.10.2

Vancouver

D T, A M, P T, SJ H, K C, WY C, et al. Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.10.2

BibTeX
@article{D2025,
  author = {D, Tatovic and A, Marwaha and P, Taylor and SJ, Hanna and K, Carter and WY, Cheung and al, et},
  title = {Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.10.2}
}
Kostenlos starten →